logo
How Trump's ‘revenge tax' brought the world to its knees

How Trump's ‘revenge tax' brought the world to its knees

Telegraph11 hours ago

When Donald Trump unveiled his 'One Big Beautiful Bill' last month, all the focus was on how the president's trillions of tax cuts might blow out America's budget bottom line.
But hidden within the bill's 1,000-plus pages was a clause that set alarm bells ringing in boardrooms at many of Britain's biggest companies.
In section 899 of the bill, Trump proposed what has become known as a 'revenge tax', which gave him a new power to punish countries that had tax regimes he didn't like.
If Britain's taxes displeased him – and they do – he could ratchet up US taxes on British companies' American operations to blood-curdling levels.
Every year, British companies would face an extra 5pc tax hit on earnings from their US operations, with the rate maxing out at 50pc.
The threat was a devastating one. British companies with big US exposure include the food giant Compass, the big pharma pair GSK and AstraZeneca, Barclays, British American Tobacco, drinks conglomerate Diageo, goods manufacturer Reckitt Benckiser and Intercontinental Hotels Group.
All are listed on the London Stock Exchange, meaning Trump's threat could have been devastating for the already beleaguered index.
The response was immediate. Business leaders and lobby groups quickly began knocking on Rachel Reeves's door, sounding the alarm and urging the Chancellor to get on the case with Scott Bessent, the US treasury secretary.
Reeves got the message. She raised the S899 tax threat with Bessent when he came to London for trade talks with the Chinese in early June.
By then, though, the bill was breezing through the House of Representatives and into the Senate, with the only change being a tweak to ensure investors in US Treasury bonds weren't affected by the 'revenge tax'.
Businesses began weighing up Plan B. All the options for coping with the revenge tax were expensive and disruptive, ranging from pulling money out of the US to beat the higher rate to scaling back US investments, or dual-listing their stock in New York. Some even considered the nuclear option of spinning off their American businesses altogether.
Fearing Trump's wrath
The public debate on S899 hasn't matched the anxiety behind closed doors. Companies were reluctant to speak out, fearing Trump's wrath.
But the clock was ticking. Trump wants his Big Beautiful Bill to become law by July 4. With less than a week to go, there was still no public sign that his team, or the Republicans in Congress, were ready to compromise.
On Thursday night, though, the tax bloodbath was averted. Bessent announced that he'd extracted surrender terms from the finance ministers of the G7 – Britain, France, Germany, Italy, Japan and Canada – and told Congress to drop section 899.
'It's a big relief,' says Emanuel Adam, a Washington-based executive director at the lobby group British American Business.
CS Venkatakrishnan, the Barclays chief, called it 'welcome progress, and a significant outcome for a great many UK companies like Barclays that invest in the US'.
But a deal with Trump always comes at a price.
The main target of s899 was efforts to impose a global minimum corporation tax, part of a OECD-led initiative, and in particular the Under-Taxed Profits Rule (UTPR). This aims to ensure that multinational companies always pay a tax rate of at least 15pc on their earnings, rather than being able to shelter profits in lower-tax countries.
Bessent says the G7 will now not impose that levy on US businesses. The risk now, observers say, is that an American exemption to the UTPR could start to unravel that whole process, sending the world back into the rabbit warren of widespread tax avoidance.
'The biggest success has been to get a load of low-tax or no-tax countries, like the Gulf states and most of the island tax havens, to up their company tax rate to 15pc,' says Tim Sarson, the head of tax policy at KPMG UK.
'If they think they can reduce that rate and attract US companies to their jurisdiction, that might start to unpick the new system more widely.'
Digital services taxes, which were one of Trump's explicit targets of s899, are still on the table. The president sees these as unfair imposts on American tech giants, but The Telegraph understands these will be fought over as part of his trade negotiations with individual countries, rather than as part of this deal.
Closer to home, there's the question of whether the s899 deal will deliver yet another blow to Reeves's already shattered Budget.
The Office for Budget Responsibility has estimated that the OECD 'Pillar Two' deal, which includes the global minimum tax rate and the UTPR, would deliver £1.3bn of extra revenue this financial year and next, climbing to £1.5bn by 2029-30.
Most of this, though, would come from a different part of Pillar Two, which targets UK companies with subsidiaries in offshore tax havens, rather than US businesses. Tax experts say revenue from the UTPR, which the UK would collect from foreign companies, would be difficult to model and likely have only a small impact on the OBR's forecast.
Price worth paying
Even if there is a hit to Britain's tax take, it may have been a price worth paying to shield Britain's corporate A-list from Trump's brutal tax.
With many blue chip companies reporting their annual or half-yearly results next month, boards were preparing and planning for the inevitable questions from alarmed shareholders.
Many were evaluating what could be done to minimise the impact in the short term, in the hope that the political weather in the US might change after the Congressional midterm elections next year and the presidential election in 2028.
'I don't think companies would have retracted their investments or stalled major plans, but it would create additional friction. Projects might have taken longer,' British American Business's Adam says.
'Companies are agile, and companies know how to adjust. But this would have consumed resources and money that could be spent on other things.'
Damage to confidence
Although the immediate crisis seems to have passed, the Trump administration may have inflicted some lingering damage on the confidence that UK companies and investors have in the US as a place to do business. It just doesn't look quite like the safe, secure and stable proposition it used to be.
Joe Dabrowski, of the Pensions and Lifetime Savings Association, says that when you add the s899 scare to the tariff threats, Trump's fight with Jerome Powell, the Federal Reserve chairman, and his radical surgery on corporate governance, the sum total is much greater uncertainty.
'It all creates an environment where investors just have to tread more carefully. There is a lot more thinking and due diligence and risk you have to factor in,' he says.
'Some of it might just be white noise and political posturing, but at times it's very difficult to tell the difference between that and reality.'
And although Reeves probably had little choice but to yield to Trump, the G7's readiness to give way has probably only increased that risk.
'There's the fear, which I'm sure UK Treasury has as well, that if you give the Americans this, then the next time they're unhappy about something, they'll try the same trick,' says KPMG's Sarson.
With the mercurial Trump barely started on his four-year term, British businesses should probably just put those contingency plans in a drawer, rather than feed them to the shredder.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US supreme court ruling sets stage for more politicized science under RFK Jr
US supreme court ruling sets stage for more politicized science under RFK Jr

The Guardian

time30 minutes ago

  • The Guardian

US supreme court ruling sets stage for more politicized science under RFK Jr

A US supreme court decision affirming the constitutionality of Obamacare sets the stage for more politicized science in the future, health law experts said about the court's decision. The court's majority opinion in Kennedy v Braidwood Management found that an expert panel – the preventive services taskforce – convened under the Affordable Care Act is under the direct oversight of the health secretary. 'This is your classic good news, bad news,' said Lawrence Gostin, a professor of global health law at Georgetown Law. 'In a sane world, with a secretary of health that believes in science and doesn't bring in conspiracy theories and agendas, you would applaud this decision.' With health policy now in the hands of the Trump administration, 'it gives Secretary [Robert F Kennedy Jr] complete power about what to recommend and what not to recommend,' Gostin said. The court issued the opinion only hours after an expert vaccine advisory panel (ACIP) handpicked by Kennedy subverted the scientific consensus by recommending against vaccines containing thimerosal, a preservative overwhelmingly considered safe. Thimerosal has been a subject of misinformation and anti-vaccine advocacy for decades. Much like the expert panel in question in the Braidwood case, the recommendations of the vaccine advisory committee are a key link in the treatment distribution pipeline. Recommendations from both panels are typically affirmed by the leadership of the health department, and then become the basis on which insurers base coverage decisions. In the case of the ACIP, those recommendations typically concern vaccines. In the preventive taskforce context, they include a wide range of treatments – from statins to cancer screenings to HIV prevention. It was widely recognized that Kennedy had the authority to hire and fire people for the vaccine panel – but legal controversy existed about whether health secretaries have the same power over the preventive services taskforce. 'The president and the Senate are accountable 'for both the making of a bad appointment and the rejection of a good one',' wrote Justice Brett Kavanaugh for the six-vote majority. In other words, the court said, if you don't like it, go to the ballot box. MaryBeth Musumeci, an associate professor of health law management at the George Washington University Milken Institute of Public Health, told the Guardian: 'We have that structure in place – and that is a really great structure if the folks in charge are actually deferring to the experts and the science and what the evidence says.' She added: 'To the extent that we are going to make decisions based on bad science – that has really serious public health implications.' The panel at the center of the vaccine decision is the ACIP vaccine panel. Until June, the advisory panel was made up of 17 experts vetted by CDC career scientists. Their recommendations, while not binding, were almost always approved by CDC leadership. Kennedy fired all 17 members unilaterally in June and stocked the panel with eight ideological allies – including vaccine skeptics and medical professionals with little experience in vaccines. One panelist withdrew after a government financial review, and after it was widely publicized that the secretary's claims about the panelist's affiliation with two universities was false. Wayne Turner, a senior attorney for the National Health Law Program, which advocates for the medically underserved, said that he and others were 'certainly breathing a sigh of relief with the court's decision today' because a key provision of Obamacare was found to be constitutional. 'But that sigh of relief is really short-lived,' Turner said. 'We have long anticipated with the appointment of RFK Jr, and certainly with his actions with the ACIP, that we can fully expect the preventive services taskforce to be the next battleground in the ideological war this administration seems to be waging. And the war is against science.' The subject of the Braidwood case provides a salient example. Plaintiffs were suing the government to claim that the taskforce was wrongly appointed. Although their legal argument was thorny, one treatment they specifically cited as wrong was insurance coverage of pre-exposure prophylaxis (PrEP), an HIV prevention drug. Although the plaintiffs' claim that the taskforce was unconstitutional was swatted down, it provides activists with a roadmap to get what they want – if they can convince Kennedy to appoint more ideological allies to the taskforce. The preventive services taskforce may have one protective mechanism: a requirement that they be guided by evidence written into Obamacare, the legislation that impaneled them. Gearing up for another fight, Turner said: 'That's going to be an important thing for us to point to in the weeks and months ahead, and years, quite frankly.'

US Senate votes down resolution to restrict Trump from escalating Iran war
US Senate votes down resolution to restrict Trump from escalating Iran war

The Guardian

time36 minutes ago

  • The Guardian

US Senate votes down resolution to restrict Trump from escalating Iran war

Senate Democrats failed on Friday to get a war-powers resolution passed to limit Donald Trump's ability to single-handedly escalate the war with Iran. The resolution, 'to direct the removal of United States Armed Forces from hostilities against the Islamic Republic of Iran', was voted down 53-47. The vote on the resolution, introduced by the Democratic senator Tim Kaine of Virginia, split along mainly partisan lines. One Republican, Rand Paul of Kentucky, voted for it; one Democrat, John Fetterman of Pennsylvania, voted against it. 'Congress declares war,' Kaine said in a speech on the Senate floor. He stressed that the framers of the US constitution in 1787 were so wary of giving the power to start wars to one person that they did not even entrust it to George Washington, the first commander-in-chief. 'They decided that war was too big a decision for one person,' Kaine said. 'And so they wrote a constitution that said the United States should not be at war without a vote of Congress.' The measure would have compelled Trump to seek authorization from Congress before taking any further military action. Trump ordered airstrikes on Iran's nuclear facilities on 22 June. This directly followed Israel launching attacks on Iran, and Iran retaliating. Trump said that the US bombardment 'totally obliterated' key nuclear enrichment facilities and deemed the mission a success, although some initial reports said the damage was minimal. Iran condemned the attacks. Trump claimed on Friday that Iran had halted its nuclear ambitions after the bombings. But, he said, he would 'absolutely' continue to attack the country's nuclear sites if he believed it was once again enriching uranium. 'Time will tell,' Trump said at the White House. 'But I don't believe that they're going to go back into nuclear anytime soon.' Later on Friday, Iran's foreign minister, Abbas Araghchi, rebuked Trump on social media. 'If President Trump is genuine about wanting a deal, he should put aside the disrespectful and unacceptable tone towards Iran's Supreme Leader, Grand Ayatollah Khamenei, and stop hurting his millions of heartfelt followers', Araghchi wrote on X. 'The Great and Powerful Iranian People, who showed the world that the Israeli regime had NO CHOICE but to RUN to 'Daddy' to avoid being flattened by our Missiles, do not take kindly to Threats and Insults', Iran's top diplomat added, in something approximating Trump's own social media style. 'If Illusions lead to worse mistakes, Iran will not hesitate to unveil its Real Capabilities, which will certainly END any Delusion about the Power of Iran.'

Trading cards offer lifeline to low-income players
Trading cards offer lifeline to low-income players

Reuters

time44 minutes ago

  • Reuters

Trading cards offer lifeline to low-income players

LONDON/NEW YORK, June 28 (Reuters) - A nearly year-old initiative to sell tennis players' trading cards is generating vital extra income for lower earners struggling to make ends meet, its backers said. While the world's elite tennis players can earn fortunes, with Wimbledon for example offering a record 53.5 million pounds ($73.5 million) in prize money this year, those much further down the rankings often struggle financially. Winners Alliance, the commercial partner of the Professional Tennis Players Association (PTPA) which wants to address the financial disparities, said the new cards had generated around $20 million since they were rolled out in August. Some 70% of the income has gone to the 400 players signed up. "You have the 100th best player in the world and they're struggling to make a living," Eric Winston, president of Winners Alliance, told Reuters. "That's not right." Winners Alliance has teamed up with the Fanatics-owned Topps brand to produce trading cards for the next 20 years, hoping to emulate the huge popularity of such initiatives in other sports such as soccer and U.S. basketball. The cards, featuring current and former players, are sold online, at hobby shops and on site at big tournaments including the U.S Open and Australian Opens. The latest release on May 15th sold out in 24 hours. Founded in 2022, Winners Alliance, chaired by hedge fund manager Bill Ackman, manages commercial opportunities for sports players and their agents. Its aim is to generate a recurring annual income of $100,000 for all ranked players from trading cards, video games and other income streams. "The level of players in the top 200 has never been so high... and some can barely make ends meet," said PTPA deputy executive director Romain Rosenberg, citing the example of a player near the top 100 who earned $25,000 one year after deducting taxes, coaching and other unavoidable costs. Rosenberg contrasted tennis with other sports such as football where even lower-tier players earn large salaries, often without the high costs tennis players face with coaching, travel and health expenses. "It is still early days but the aim is to emulate the success of U.S. basketball and baseball leagues... even reaching 10% of their revenue in five to 10 years would generate meaningful passive income for players," Rosenberg added. The PTPA, co-founded by players Novak Djokovic and Vasek Pospisil in 2020, has backed various efforts to level the playing field between the haves and have-nots of tennis, including legal aid and health programmes. Sports trading cards have enjoyed enduring popularity, buoyed by record-breaking sales such as a rookie card of baseball great Mickey Mantle fetching $12.6 million at auction in 2022.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store